Skip to main content

Table 3 Relationship between morphological features, kinetics patterns of enhancement and biological parameters

From: Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer

Biological Parameters

 

Morphological features

Kinetic features

  

Margin

Enhancement internal

 

Peak of maximum enhancement

% of maximum enhancement < 2'

Curve Type

 

N°*

A

B

Hom

Het/Rim

 

< 2'

≥ 2'

≤ 150%

> 150%

I

II

III

Total cases

64

    

68

       

Estrogen receptors**

             

   Negative

13

3 (23.1)

10 (76.9)

2 (15.4)

11 (84.6)

14

3 (21.4)

11 (78.6)

9 (64.3)

5 (35.7)

-

9 (64.3)

5 (35.7)

   Positive

51

13 (25.5)

38 (74.5)

10 (19.6)

41 (80.4)

54

14 (25.9)

40 (74.1)

30 (55.6)

24 (44.4)

5 (9.2)

15 (27.8)

34 (63)

Progesterone receptors**

             

   Negative

18

4 (22.2)

14 (77.8)

3 (16.7)

15 (83.3)

20

6 (30)

14 (70)

12 (60)

8 (40)

-

9 (45)

11 (55)

   Positive

46

12 (26.1)

34 (73.9)

9 (19.6)

37 (80.4)

48

11 (22.9)

37 (77.1)

27 (56.3)

21 (43.7)

5 (10.4)

15 (31.3)

28 (58.3)

p53**

             

   Negative

52

11 (21.2)

41 (78.8)

9 (17.3)

43 (82.7)

56

14 (25)

42 (75)

31 (55.4)

25 (44.6)

5 (8.9)

19 (33.9)

32 (57.2)

   Positive

12

5 (41.7)

7 (58.3)

3 (25)

9 (75)

12

3 (25)

9 (75)

8 (66.7)

4 (33.3)

-

5 (41.7)

7 (58.3)

HER2**

             

   Negative

38

10 (26.3)

28 (73.7)

8 (21.1)

30 (78.9)

41

9 (22)

32 (78)

23 (56.1)

18 (43.9)

5 (12.2)

15 (36.6)

21 (51.2)

   Positive

26

6 (23.1)

20 (76.9)

4 (15.4)

22 (84.6)

27

8 (29.6)

19 (70.4)

16 (59.3)

11 (40.7)

-

9 (33.3)

18 (66.7)

Ki67**

64

17.5

(3-85)

20

(1-95)

17.5

(5-85)

20

(1-95)

68

20

(3-95)

15

(1-85)

20

(1-85)

15

(1-95)

5

(5-45)

15

(1-85)

20

(3-95)

VEGFR-1#

64

59.4

(0-216.1)

54.8

(0-191)

60.7

(0-216.1)

54.2

(0-191)

68

53.6

(0-216.1)

54.7

(0-191)

56.5

(0-216.1)

49.6

(0-139.5)

0

(0-103.4)

50.2

(0-145.8)

56.5

(0-216.1)

VEGFR-2#

64

40.9

(0-126.8)

37.7

(0-155.5)

18.8

(0-155.5)

39.7

(0-140.9)

68

39.2

(0-122.1)

34.1

(0-155.5)

36.2

(0-133.6)

32.8

(0-155.5)

0

(0-56.2)

34

(0-155.5)

39.2

(0-140.9)

  1. * Four cases showed a non-nodular enhancement, so the morphological features were analyzed in only 64 cases, and the kinetic features in all 68 cases.
  2. **Data are expressed as number of cases (percentage).
  3. # Data are expressed as median (range).
  4. Abbreviations: A, well-defined (regular); B, ill-defined (irregular o spiculated); Hom: homogeneous; Het: heterogeneous.